Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Reconstitution of a hierarchical +TIP interaction network controlling microtubule end tracking of dynein

Abstract

Growing microtubule end regions recruit a variety of proteins collectively termed +TIPs, which confer local functions to the microtubule cytoskeleton1. +TIPs form dynamic interaction networks whose behaviour depends on a number of potentially competitive and hierarchical interaction modes2. The rules that determine which of the various +TIPs are recruited to the limited number of available binding sites at microtubule ends remain poorly understood. Here we examined how the human dynein complex, the main minus-end-directed motor and an important +TIP (refs 2, 3, 4), is targeted to growing microtubule ends in the presence of different +TIP competitors. Using a total internal reflection fluorescence microscopy-based reconstitution assay, we found that a hierarchical recruitment mode targets the large dynactin subunit p150Glued to growing microtubule ends via EB1 and CLIP-170 in the presence of competing SxIP-motif-containing peptides. We further show that the human dynein complex is targeted to growing microtubule ends through an interaction of the tail domain of dynein with p150Glued. Our results highlight how the connectivity and hierarchy within dynamic +TIP networks are orchestrated.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: SxIP-motif-containing peptides disrupt EB1-mediated targeting of p150 to growing microtubule ends.
Figure 2: SxIP motif and CAP-Gly domain binding to EB1 is mutually exclusive.
Figure 3: CLIP-170 restores EB1-dependent end tracking of p150 in the presence of SxIP peptides.
Figure 4: EB1 and p150 target the human dynein complex to growing microtubule ends.

Similar content being viewed by others

References

  1. Duellberg, C., Fourniol, F. J., Maurer, S. P., Roostalu, J. & Surrey, T. End-binding proteins and Ase1/PRC1 define local functionality of structurally distinct parts of the microtubule cytoskeleton. Trends Cell Biol. 23, 54–63 (2013).

    Article  CAS  PubMed  Google Scholar 

  2. Akhmanova, A. & Steinmetz, M. O. Tracking the ends: a dynamic protein network controls the fate of microtubule tips. Nat. Rev. Mol. Cell Biol. 9, 309–322 (2008).

    Article  CAS  PubMed  Google Scholar 

  3. Gennerich, A. & Vale, R. D. Walking the walk: how kinesin and dynein coordinate their steps. Curr. Opin. Cell Biol. 21, 59–67 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Moughamian, A. J., Osborn, G. E., Lazarus, J. E., Maday, S. & Holzbaur, E. L. Ordered recruitment of dynactin to the microtubule plus-end is required for efficient initiation of retrograde axonal transport. J. Neurosci. 33, 13190–13203 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Maurer, S. P., Fourniol, F. J., Bohner, G., Moores, C. A. & Surrey, T. EBs recognize a nucleotide-dependent structural cap at growing microtubule ends. Cell 149, 371–382 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Bieling, P. et al. Reconstitution of a microtubule plus-end tracking system in vitro. Nature 450, 1100–1105 (2007).

    Article  CAS  PubMed  Google Scholar 

  7. Akhmanova, A. & Steinmetz, M. O. Microtubule +TIPs at a glance. J. Cell Sci. 123, 3415–3419 (2010).

    Article  CAS  PubMed  Google Scholar 

  8. Honnappa, S. et al. An EB1-binding motif acts as a microtubule tip localization signal. Cell 138, 366–376 (2009).

    Article  CAS  PubMed  Google Scholar 

  9. Jiang, K. et al. A proteome-wide screen for mammalian SxIP motif-containing microtubule plus-end tracking proteins. Curr. Biol. 22, 1800–1807 (2012).

    Article  CAS  PubMed  Google Scholar 

  10. Kobayashi, T. & Murayama, T. Cell cycle-dependent microtubule-based dynamic transport of cytoplasmic dynein in mammalian cells. PLoS ONE 4, e7827 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  11. Splinter, D. et al. BICD2, dynactin, and LIS1 cooperate in regulating dynein recruitment to cellular structures. Mol. Biol. Cell 23, 4226–4241 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Vaughan, K. T., Tynan, S. H., Faulkner, N. E., Echeverri, C. J. & Vallee, R. B. Colocalization of cytoplasmic dynein with dynactin and CLIP-170 at microtubule distal ends. J. Cell Sci. 112, 1437–1447 (1999).

    CAS  PubMed  Google Scholar 

  13. Moore, J. K., Stuchell-Brereton, M. D. & Cooper, J. A. Function of dynein in budding yeast: mitotic spindle positioning in a polarized cell. Cell Motil. Cytoskeleton 66, 546–555 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Moughamian, A. J. & Holzbaur, E. L. Dynactin is required for transport initiation from the distal axon. Neuron 74, 331–343 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Zhang, J. et al. The microtubule plus-end localization of Aspergillus dynein is important for dynein-early-endosome interaction but not for dynein ATPase activation. J. Cell Sci. 123, 3596–3604 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Yamada, M. et al. LIS1 and NDEL1 coordinate the plus-end-directed transport of cytoplasmic dynein. EMBO J. 27, 2471–2483 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Vaughan, K. T. & Vallee, R. B. Cytoplasmic dynein binds dynactin through a direct interaction between the intermediate chains and p150Glued. J. Cell Biol. 131, 1507–1516 (1995).

    Article  CAS  PubMed  Google Scholar 

  18. Schroer, T. A. Dynactin. Annu. Rev. Cell Dev. Biol. 20, 759–779 (2004).

    Article  CAS  PubMed  Google Scholar 

  19. King, S. J. & Schroer, T. A. Dynactin increases the processivity of the cytoplasmic dynein motor. Nat. Cell Biol. 2, 20–24 (2000).

    Article  CAS  PubMed  Google Scholar 

  20. Ahmed, S., Sun, S., Siglin, A. E., Polenova, T. & Williams, J. C. Disease-associated mutations in the p150(Glued) subunit destabilize the CAP-gly domain. Biochemistry 49, 5083–5085 (2010).

    Article  CAS  PubMed  Google Scholar 

  21. Farrer, M. J. et al. DCTN1 mutations in Perry syndrome. Nat. Genet. 41, 163–165 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Honnappa, S. et al. Key interaction modes of dynamic +TIP networks. Mol. Cell 23, 663–671 (2006).

    Article  CAS  PubMed  Google Scholar 

  23. Lansbergen, G. Conformational changes in CLIP-170 regulate its binding to microtubules and dynactin localization. J. Cell Biol. 166, 1003–1014 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Watson, P. Microtubule plus-end loading of p150Glued is mediated by EB1 and CLIP-170 but is not required for intracellular membrane traffic in mammalian cells. J. Cell Sci. 119, 2758–2767 (2006).

    Article  CAS  PubMed  Google Scholar 

  25. Bieling, P. et al. CLIP-170 tracks growing microtubule ends by dynamically recognizing composite EB1/tubulin-binding sites. J. Cell Biol. 183, 1223–1233 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Mishima, M. et al. Structural basis for tubulin recognition by cytoplasmic linker protein 170 and its autoinhibition. Proc. Natl Acad. Sci. USA 104, 10346–10351 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Weisbrich, A. et al. Structure–function relationship of CAP-Gly domains. Nat. Struct. Mol. Biol. 14, 959–967 (2007).

    Article  CAS  PubMed  Google Scholar 

  28. Hayashi, I., Plevin, M. J. & Ikura, M. CLIP170 autoinhibition mimics intermolecular interactions with p150Glued or EB1. Nat. Struct. Mol. Biol. 14, 980–981 (2007).

    Article  CAS  PubMed  Google Scholar 

  29. Hayashi, I., Wilde, A., Mal, T. K. & Ikura, M. Structural basis for the activation of microtubule assembly by the EB1 and p150Glued complex. Mol. Cell 19, 449–460 (2005).

    Article  CAS  PubMed  Google Scholar 

  30. Zhapparova, O. N. et al. Dynactin subunit p150Glued isoforms notable for differential interaction with microtubules. Traffic 10, 1635–1646 (2009).

    Article  CAS  PubMed  Google Scholar 

  31. Dixit, R., Levy, J. R., Tokito, M., Ligon, L. A. & Holzbaur, E. L. F. Regulation of dynactin through the differential expression of p150Glued isoforms. J. Biol. Chem. 283, 33611–33619 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Buey, R. M. et al. Sequence determinants of a microtubule tip localization signal (MtLS). J. Biol. Chem. 287, 28227–28242 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Sun, L., Liu, A. & Georgopoulos, K. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J. 15, 5358–5369 (1996).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Hoogenraad, C. C. et al. Targeted mutation of Cyln2 in the Williams syndrome critical region links CLIP-115 haploinsufficiency to neurodevelopmental abnormalities in mice. Nat. Genet. 32, 116–127 (2002).

    Article  CAS  PubMed  Google Scholar 

  35. Vaughan, P. S., Miura, P., Henderson, M., Byrne, B. & Vaughan, K. T. A role for regulated binding of p150(Glued) to microtubule plus ends in organelle transport. J. Cell Biol. 158, 305–319 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Trokter, M., Mucke, N. & Surrey, T. Reconstitution of the human cytoplasmic dynein complex. Proc. Natl Acad. Sci. USA 109, 20895–20900 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Leśniewska, K., Warbrick, E. & Ohkura, H. Peptide aptamers define distinct EB1- and EB3-binding motifs and interfere with microtubule dynamics. Mol. Biol. Cell 25, 1025–1036 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  38. Kumar, P. et al. Multisite phosphorylation disrupts arginine-glutamate salt bridge networks required for binding of cytoplasmic linker-associated protein 2 (CLASP2) to end-binding protein 1 (EB1). J. Biol. Chem. 287, 17050–17064 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Li, H. et al. Phosphorylation of CLIP-170 by Plk1 and CK2 promotes timely formation of kinetochore-microtubule attachments. EMBO J. 29, 2953–2965 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Lee, H. S. et al. Phosphorylation controls autoinhibition of cytoplasmic linker protein-170. Mol. Biol. Cell 21, 2661–2673 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Weng, J. H. et al. Pregnenolone activates CLIP-170 to promote microtubule growth and cell migration. Nat. Chem. Biol. 9, 636–642 (2013).

    Article  CAS  PubMed  Google Scholar 

  42. Maurer, S. P. et al. EB1 accelerates two conformational transitions important for microtubule maturation and dynamics. Curr. Biol. 24, 372–384 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Honnappa, S., John, C. M., Kostrewa, D., Winkler, F. K. & Steinmetz, M. O. Structural insights into the EB1-APC interaction. EMBO J. 24, 261–269 (2005).

    Article  CAS  PubMed  Google Scholar 

  44. Montenegro Gouveia, S. et al. In vitro reconstitution of the functional interplay between MCAK and EB3 at microtubule plus ends. Curr. Biol. 20, 1717–1722 (2010).

    Article  CAS  PubMed  Google Scholar 

  45. Scheel, J. et al. Purification and analysis of authentic CLIP-170 and recombinant fragments. J. Biol. Chem. 274, 25883–25891 (1999).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank R. M. Buey for cloning of the p150–GCN4 construct, I. Lüke for help with insect cell culture and protein expressions, the Peptide Chemistry facility LRI for peptide synthesis, J. Roostalu for Atto488-labelled tubulin, N. Cade for microscopy support and critical reading of the manuscript, and H. Walden for useful advice on protein purification. C.D. and T.S. acknowledge financial support from the European Research Council (ERC project ID 323042) and the German Research Foundation (DFG SU 175/7-1). M.O.S. is supported by a grant from the Swiss National Science Foundation (310030B_138659).

Author information

Authors and Affiliations

Authors

Contributions

C.D. performed experiments, C.D., M.T., R.J. and I.S. prepared reagents, and C.D., M.O.S. and T.S. analysed data, designed research and wrote the manuscript.

Corresponding author

Correspondence to Thomas Surrey.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Integrated supplementary information

Supplementary Figure 1 EB1 targets the neuronal splice variant of p150 to growing microtubule ends in vitro.

(a) Top: Schematics illustrating the difference between the tissue and neuronal p150 isoforms: insertion of a positively charged stretch of 20 amino acids, encoded by exons 5–7. Note: In the main figures, the addition ‘-T’ is omitted, because only experiments with the tissue form of p150 (except in Fig. 2d) are shown there. Bottom: Schematics illustrating the composition of the p150 constructs used for the experiments shown in this figure: mCherry labelled neuronal and tissue p150 isoforms containing the first 547 and 527 amino acids of p150 (mCherry-p150547-N and mCherry-p150527-T, ending at corresponding amino acid positions), respectively; GFP-labelled neuronal p150 isoform containing the first 218 amino acids (with the CAP-Gly domain and the basic domain) followed by the artificial dimerization domain GCN4 (p150218GCN4-N). This latter construct was made for comparison with previously published work4. (b) Illustration of the conversion of a time series (top) to a kymograph (‘space-time plot’, bottom). Example images and corresponding kymographs of a time series (corresponding to Fig. 1b) are shown for the individual fluorescent channels (middle and right) as well as their merge (left, with mCherry-p150 in green and Cy5-microtubules in red). (c) Left column: Dual (top) and single colour overview images (middle) and representative kymographs (bottom) of 125 nM mCherry-p150547-N (green) tracking growing Cy5-microtubule (red) ends in the presence of 150 nM unlabelled EB1. Remaining panels: Comparison of the microtubule binding strength of the two p150 isoforms in the absence of EB1: dual (top) and single (middle) colour overview images and a single colour time-averaged images (from 60 consecutive frames; bottom) showing 125 nM mCherry-p150547-N (green in merge, left pair of columns) or 125 nM mCherry-p150527-T (green in merge, right pair of columns) binding along Cy5-microtubules (red in merge) in Standard TIRFM buffer or standard TIRFM buffer without KCl, as indicated. (d) An overview dual colour TIRF microscopy image (left) and single and dual colour kymographs (right) of 10 nM GFP-p150218GCN4-N (green in merge) tracking growing ends of Cy5-microtubules (red in merge) in the presence of 150 nM unlabelled EB1. Standard TIRFM buffer was supplemented with additional 25 mM KCl and 85 mM K-acetate, which was necessary to keep this construct soluble and to reduce its overall microtubule binding strength. (e) Three colour experiment showing that mCherry-EB3 recruits Alexa647-p150547-N to growing microtubule ends. Left: overview images of 150 nM mCherry-EB3 (top, blue) and 75 nM Alexa647-p150547-N (bottom, green) on Cy5-microtubules (red) in Standard TIRFM buffer (the same image frames are shown). Right: Single colour and merged triple colour kymographs of a representative microtubule in the same experiment (same colour code in merge). Cy5-tubulin concentration was always 20 μM. Horizontal and vertical scale bars are 3 μm and 20 s, respectively. Taken together, these results show that despite the stronger binding of the neuronal p150 isoform to microtubules, both the neuronal and the tissue isoform can track growing microtubule ends in an EB dependent manner (irrespective of the construct of the neuronal isoform used and irrespective of whether EB1 or EB3 is used).

Supplementary Figure 2 CLIP-170 without a putative SxIP motif competes with SxIP peptides for EB1 binding at growing microtubule ends.

(a) Schematic of a mutated version of GFP-CLIP-170ΔC with a putative SxIP motif between the CAP-Gly domains changed to SxNN (GFP-CLIP-170ΔCSxNN). (b) Representative dual-colour images (top) and kymographs (bottom) of 75 nM GFP-CLIP-170ΔC (green, left) or 75 nM GFP-CLIP-170ΔCSxNN (green, right) in the presence of 150 nM unlabelled EB1 and either no additional SxIP peptide or with 15 μM unlabelled SxIP peptide, as indicated. Cy5-microtubules (red) elongated from immobilised seeds in the presence of 20 μM Cy5-tubulin in Standard TIRFM buffer. Horizontal and vertical scale bars are 3 μm and 20 s, respectively. (c) Quantification of fluorescence intensities of the GFP-CLIP-170ΔC and GFP-CLIP-170ΔCSxNN at microtubule end regions and on the microtubule lattice in the presence of unlabelled EB1 and in the presence or absence of competing unlabelled SxIP peptides. Error bars are standard errors of the mean (s.e.m.) and are derived from at least 250 individual frames per condition from 3 independent experiments. These experiments show that GFP-CLIP-170ΔC and GFP-CLIP-170ΔCSxNN are both recruited to growing microtubule ends by EB1 without a significant difference. GFP-CLIP-170ΔCSxNN is also displaced from EB1 at growing microtubule ends by an excess of SxIP peptides, similar to wild type GFP-CLIP-170ΔC. This demonstrates that the putative SxIP motif of CLIP-170 does not contribute significantly to binding of CLIP-170 to EB1, even in the context of the native flanking CLIP-170 domains. This confirms previous results with a short CLIP-170 sequence peptide32 and demonstrates that the CAP-Gly domains, and not the putative SxIP sequence in CLIP-170 are responsible for the competition between CLIP-170 and SxIP peptides for EB binding.

Supplementary Figure 3 An intact distal zinc knuckle of CLIP-170 is required for efficient interaction with the CAP-Gly domain of p150.

(a) Schematics of mCherry-EB3, of the GFP-labelled tissue p150 isoform containing the first 198 amino acids of p150 followed by the artificial dimerisation domain GCN4 (GFP-p150198GCN4-T), and of a construct comprising the final 40 amino acids of CLIP-170 containing the distal zinc knuckle domain and the C-terminal EEY/F motif (CLIP-C40). A thioredoxin tag on CLIP-C40 was added to improve solubility (solubility tag). (b) Single and triple colour kymographs showing the localisation of 75 nM mCherry-EB3 (red in merge) and 20 nM GFP-p150198GCN4-T (green in merge) on a Cy5-microtubule (blue in merge) in the presence of 660 nM unlabelled CLIP-C40 (C-terminal 40 amino acids of CLIP-170), used here as a sequestering agent, in the absence (left) and presence (right) of 5 mM EGTA. EGTA chelates zinc ions33 and is therefore expected to unfold the zinc knuckle domain of CLIP-170. Standard TIRFM buffer without or with 5 mM EGTA was used as indicated. We observe that the localisation of mCherry-EB3 (used here instead of EB1, because N-terminal fusions with fluorescent proteins tend to impair EB1, but not EB3 activity) to growing microtubule ends is unaffected by EGTA, but that GFP-p150198GCN4-T localises to microtubule ends only in the presence of EGTA. This demonstrates that CLIP-C40 efficiently sequesters GFP-p150218GCN4-T in solution only in the absence of EGTA when the distal zinc knuckle domain of CLIP-170 is properly folded. This supports the conclusion from Figs 13 that the CAP-Gly domain of p150 can either interact at microtubule ends with the C-terminal part of EBs or with the C-terminal part of EB-recruited CLIP-170. (c) Left: Representative overview images (top) and kymographs (bottom) showing 150 nM unlabelled EB1 targeting 10 nM p150218GCN4-N (green) to the ends of growing Cy5-microtubules (red) only in the absence (left), but not in the presence (right) of unlabelled 660 nM CLIP-170ΔC. Standard TIRFM buffer was supplemented with additional 25 mM KCl and 85 mM K-acetate, which was necessary to keep this construct soluble and to reduce its overall microtubule binding strength. This experiment provides evidence that the N-terminal part of CLIP-170 competes with p150 for EB1 binding at growing microtubule ends. Cy5-tubulin concentration was always 20 μM. Horizontal and vertical scale bars are 3 μm and 20 s, respectively. Right: The scheme illustrates the competition between the N-terminal part of CLIP-170 and p150 for EB1 binding at growing microtubule ends.

Supplementary Figure 4 CLIP-170-mediated recruitment of p150 does not require a direct interaction between EB1 and p150.

(a) Scheme of a fusion protein consisting of EB1 lacking its 4 most C-terminal amino acids followed by the 40 most C-terminal amino acids of CLIP-170 (EB1ΔEEY-CLIP-C40). This fusion protein contains the EBH domain that interacts with both SxIP peptides and with the CAP-Gly domain of p150, but lacks the terminal EEY sequence of EB1 known to also interact with the p150 CAP-Gly domain (see Table 1); instead of the terminal EEY sequence of EB1 the construct contains the distal zinc knuckle and the EEY/F tail motif of CLIP-170 that interact with the CAP-Gly domain of p150, but not with SxIP motif peptides. A thioredoxin tag was added to improve solubility. (b) Single and dual colour kymographs showing that 150 nM unlabelled EB1 (left column of panels) as well as 150 nM unlabelled EB1ΔEEY-CLIP-C40 (second column) recruits 20 nM GFP-p150198GCN4-T (top kymograph, green in bottom merge) to the ends of growing Cy5-microtubules (middle kymograph, and red in bottom merge). This interaction cannot be strongly suppressed by the additional presence of a large excess of 60 μM unlabelled SxIP peptide (far right), although SxIP peptides are recruited by the EB1ΔEEY-CLIP-C40 fusion protein (third column of panels) as demonstrated by end tracking of 150 nM Fluo-SxIP (top kymograph, green in bottom merge). This means that the interaction between the zinc knuckle domain of the EB1ΔEEY-CLIP-C40 fusion protein and the p150 CAP-Gly domain is sufficient to rescue recruitment of p150 in the presence of competing SxIP motif peptides (see Fig. 3) that occupy the EBH domain of EB1. The EEY/F motif of EB1 that is absent in the EB1ΔEEY-CLIP-C40 fusion is not required for this rescue. Representative two or single-colour kymographs for each condition are depicted. ‘488’ indicates excitation at 488 nm which excites either GFP fused to p150 constructs or fluorescein covalently linked to SxIP peptide. Cy5-tubulin concentration was 20 μM. Experiments were performed in TIRFM buffer without EGTA (Methods). Horizontal and vertical scale bars are 3 μm and 20 s, respectively. (c) Scheme illustrating non-competitive binding of SxIP peptides and p150 to the EB1ΔEEY-CLIP-C40 fusion protein: SxIP peptides bind to the EBH domain and the CAP-Gly domain of p150 binds to the sequence corresponding to the C-terminal part of CLIP-170.

Supplementary Figure 5 Purity of recombinant proteins.

Coomassie-stained SDS-PAGE gels of the purified proteins, as indicated. The double band seen for mCherry constructs is likely due to different maturation forms of mCherry as reported previously. Mass spectrometry analysis supported this by showing that both bands correspond to the expected construct and not to a potential contaminant or truncated protein (data not shown).

Supplementary information

Supplementary Information

Supplementary Information (PDF 907 kb)

EB1 targets p150 to microtubule ends.

Time-lapse TIRF microscopy movie depicting the localisation of 125 nM mCherry-p150 (green) on dynamic Cy5-labelled microtubules (red) in the presence of 150 nM unlabelled EB1. This video corresponds to Fig. 1b. The time stamp (upper left corner) is in seconds. Scale bar: 5 μm. (AVI 17188 kb)

CLIP-170 restores EB1-dependent end tracking of p150 in the presence of SxIP peptides.

Time-lapse TIRF microscopy movies depicting the localisation of 75 nM mCherry-p150 (green) on dynamic Cy5-labelled microtubules (red) in the presence of 150 nM unlabelled EB1 and 6 μM SxNN control peptide (left), 6 μM SxIP peptide (middle) or 6 μM SxIP peptide with additional 75 nM GFP-CLIP-170 (right). Note: GFP-CLIP-170 is not shown here. This video corresponds to Fig. 3a. The time stamp (upper left corner) is in seconds. Scale bar: 5 μm. (AVI 30791 kb)

EB1 and p150 target the dynein complex to microtubule ends.

Time-lapse TIRF microscopy movies depicting the localisation of 14 nM mGFP-tagged human dynein complex (green) on dynamic Cy5-labelled microtubules (red) in the presence of 200 nM EB1 and 125 nM mCherry-p150 (A; left) or in the presence of 200 nM EB1 but without mCherry-p150 (B; middle). EB1 and mCherry-p150 fail to target a tail-less mGFP-tagged dimer of the dynein motor domain (green) to microtubule ends (C; right). Note: mCherry-p150 is not shown here. This video corresponds to Fig. 4b. The time stamp (upper left corner) is in seconds. Scale bar: 5 μm. (AVI 21020 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Duellberg, C., Trokter, M., Jha, R. et al. Reconstitution of a hierarchical +TIP interaction network controlling microtubule end tracking of dynein. Nat Cell Biol 16, 804–811 (2014). https://doi.org/10.1038/ncb2999

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncb2999

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing